News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Myeloproliferative Neoplasms (MF – PV – ET)
October 6, 2025
Diet Intervention in MPNs – Is the Mediterranean Diet the Answer?
Charles H. Weaver, MD
August 5, 2025
Myeloproliferative Neoplasms and Fatigue
Charles H. Weaver, MD
August 1, 2025
Overview of Polycythemia Vera
Charles H. Weaver, MD
March 7, 2025
Mast Cells and Histamine in MPN Related Itching Explained
Charles H. Weaver, MD
April 8, 2024
Treatment of Myelofibrosis
Charles H. Weaver, MD
April 8, 2024
Myeloproliferative Neoplasms Greatly Affect Patient Quality of Life
Charles H. Weaver, MD
January 1, 2024
Fatigue, Anemia and Myeloproliferative Neoplasms
Charles H. Weaver, MD
September 3, 2023
Overview of Essential Thrombocythemia
Charles H. Weaver, MD
October 29, 2022
FDA Approves Pemazyre for Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
Charles H. Weaver, MD
September 19, 2021
Dacogen Effective in Advanced Myeloproliferative Neoplasms
Charles H. Weaver, MD
September 19, 2021
Jakafi Does Not Increase Risk of New Cancers
Charles H. Weaver, MD
June 17, 2021
Rusfertide-a New Option to Avoid Phlebotomy
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
